Abiopharma

News list

Director Mullings Paul E 🟢 acquired 17.0K shares of AGNC Investment Corp. (AGNC) Transaction Date: Apr 16, 2026 | Filing ID: 000084

Full text

News bot April 17, 2026, 8:02 p.m.
🔍 Mullings Paul E (Director)

Company: AGNC Investment Corp. (AGNC)

Report Date: 2026-04-16
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 17,045
Detailed Transactions and Holdings:
- Acquired 17,045 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-04-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 156,686.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Amended and Restated AGNC Investment Corp. 2016 Equity and Incentive Compensation Plan. The awards were received as a grant for no consideration. The Common Stock underlying the RSUs will vest, subject to certain limitations, on the earlier of (i) April 16, 2027 or (ii) the next annual meeting of stockholders.
- F2: Includes 11,130 dividend equivalent restricted stock units received on previously granted RSU awards since the Reporting Person's last Form 4 filing.